Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1511 per EA under NDC 62135049130. Its NADAC has been published 230 times since Mar 30, 2022.
FDA first approved this application on Nov 14, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135049130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205869FDA Approved
11/14/2018
TE Code
AB
On Market Since
5/9/2019
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 230 times since Mar 30, 2022, and over the history we have for it it has risen 13.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per EA |
|---|---|
| All-time high | $0.1535 (Jul 15, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1362 |
| Average price | $0.1328 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 230 |
| Tracking since | Mar 30, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Chartwell RX LLC, is $0.1511 per EA (NDC 62135049130), effective Aug 19, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 13.0%. It has been tracked across 230 weekly CMS publications since Mar 30, 2022.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Mar 30, 2022, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jul 15, 2026), with a median of $0.1362 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LETROZOLE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 62135049130) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.